Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 2 hours 44 min ago

Janssen hands back rights to Hanmi's diabetes/obesity drug

04/07/2019
The drug "fell short" of Janssen's expectations on blood glucose control in obese patients

GSK launches PhIII programme for otilimab in RA

04/07/2019
The Phase III clinical programme is the first in RA to include head-to-head comparisons of otilimab with current treatments across all pivotal studies

New healthcare comms agency launches in the UK

04/07/2019
The agency is promising “high quality, creative campaigns” and close contact with senior directors throughout concept to conclusion

Prescribing support tech saving the NHS millions of pounds

04/07/2019
GPs and other prescribers were prompted more than 5 million times over a year to encourage patients to take action to self-care rather than relying on medication from their doctor, saving the NHS millions of pounds

EU approval for Alexion's PNH drug Ultomiris

04/07/2019
The European Commission has approved Alexion Pharmaceuticals' Ultomiris (ravulizumab) for the treatment of some adults with the ultra-rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH).

Industry leading companies commit to the 2019 Marketer of the Year competition

04/07/2019
With the entries for the 2019 competition well underway, PharmaTimes have seen a large number of industry leading companies putting their best individuals and teams forward.

LEO Pharma completes Bayer prescription dermatology business acquisition

03/07/2019
Under the terms of the agreement, LEO Pharma has now acquired the global product rights for Bayer’s global prescription dermatology business with the exception of Afghanistan and Pakistan.

Children’s hospices to receive £25m a year as part of NHS Long Term Plan

03/07/2019
NHS England’s hospice grant programme currently provides £12 million a year for children’s hospices.

Obesity now leading cause of four cancers

03/07/2019
Cancer Research UK has launched a new public awareness campaign and is urging the government to act, as the number of people who are obese outnumbers those who smoke two to one

ViiV secures EU nod for HIV therapy Dovato

03/07/2019
Availability of the two-drug regimen is considered a significant development for people with the condition

NICE approves CDF funding for Sanofi's Libtayo

03/07/2019
Around 560 patients per year with cutaneous squamous cell carcinoma are thought to be eligible for treatment with the drug in England

Mundipharma picks up rights to Herceptin biosimilar Tuznue

03/07/2019
The deals allows the firm to market and distribute the drug in selected European countries following its approval

NICE pushes social prescribing for dementia

02/07/2019
Health and social care secretary Matt Hancock says he “Wholeheartedly endorses” the quality standard.

Cancer Research UK, SV Health Investors team up for speedy drug development

02/07/2019
Cancer Research UK will collaborate closely with SV to identify promising, novel research from within the charity’s network that could be rapidly developed.

Libtayo bags EU approval for skin cancer

02/07/2019
The European Commission has granted conditional marketing authorisation for the drug for patients who are not candidates for curative surgery or curative radiation.

Research supports better integration of patient voice in health technology assessments

02/07/2019
The research will help ensure new treatments reflect the needs and preferences of patients and family members living with myeloma and other conditions.

RCGP responds to primary care network roll-out

01/07/2019
Professor Helen Stokes-Lampard, chair of the Royal College of GPs believes the newly-launched primary care networks have "undeniable benefits."

Wrong information creating ‘dangerous screening gap’ in cervical cancer

01/07/2019
The NHS reminds the public that any sexual activity can pass on the virus which causes the vast majority of cervical cancers.

AZ bags two extensions in latest CHMP decisions

01/07/2019
The Committee also recommended granting a marketing authorisation for La Jolla’s Giapreza, among other decisions.

Parkinson’s UK to inject £1m into drug development

01/07/2019
The charity is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells.

Pages

X